COMMUNIQUÉS West-GlobeNewswire

Vaxart Announces Adjournment of Annual Meeting of Stockholders
21/05/2025
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, [...]
L’Assemblée Générale Mixte de Cellectis se tiendra le 26 juin 2025
21/05/2025
NEW YORK, 21 mai 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome TALEN® pour développer de [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
21/05/2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
21/05/2025
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending human longevity and healthy aging through [...]
Olema Oncology to Participate in Upcoming Investor Conferences
21/05/2025
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
21/05/2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy [...]
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
21/05/2025
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancer Presentation of data at the European Lung Cancer [...]
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
21/05/2025
Traitement du premier patient dans l’étude CONVERGE, un essai clinique contrôlé randomisé de Phase 2 chez des patients atteints d’un cancer du poumon non à petites cellules (CPNPC) non résécable de stade 3. Présentation [...]
Codexis to Participate in Jefferies Global Healthcare Conference
21/05/2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will [...]
Maravai LifeSciences Releases 2024 Sustainability Report
21/05/2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy [...]
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
21/05/2025
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical data this week as [...]
Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis
21/05/2025
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company [...]
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
21/05/2025
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (" MediPharm " or the " Company "), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its shareholders to [...]
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
21/05/2025
Presentation to be webcast at 1:00 p.m. ET NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company [...]
Joule Health & Wellbeing Offers Same-Day Stress Support, Providing a Scalable Solution for HR Leaders Addressing Burnout
21/05/2025
Spokane, WA , May 21, 2025 (GLOBE NEWSWIRE) -- In recognition of Mental Health Awareness Month, Joule Health & Wellbeing has expanded its offerings to include same-day stress support —a scalable solution designed to [...]
Ipsen S.A. - Annual General Meeting held on 21 May 2025
21/05/2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders’ vote have been adopted PARIS, FRANCE, 21 May 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announces today that the [...]
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
21/05/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Assemblée Générale Annuelle d’Ipsen S.A. du 21 mai 2025 Toutes les résolutions soumises au vote des actionnaires [...]
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies
21/05/2025
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE Immunotherapeutics to lead French consortium with Inside Therapeutics and MiNT Laboratory (University of Angers) secures €1 [...]
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm
21/05/2025
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm OSE Immunotherapeutics, chef de file d’un consortium français aux côtés d’Inside Therapeutics et du [...]

Pages